semaglutide india injection With the launch of Obeda®, India's first DCGI-approved for Type 2 Diabetes, we are excited to support diabetes care in with high-quality, accessible and affordable treatment. In a head-to-head Business | Danish drugmaker Novo

The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry The rapid rise of GLP-1 weight loss medications is creating profound shifts across Britain's food and beverage sector, with new research showing adoption has nearly tripled in just two years and is already eroding demand in traditionally resilient snacking categories

Thiamine supplementation improves blood glucose levels and reduces urinary albumin excretion, possibly reversing early-stage diabetic nephropathy

Most patients choose this Mounjaro Tirzepatide the strongest option, up to 20.9% in trials (SURMOUNT1)

The dosage may be increased to up to 2mg per week if additional glycemic control is needed